With reference to its letter dated 8th October 2025, informing about the Board meeting scheduled on Monday, 3rd November 2025 to consider and take on record the unaudited financial results for the second quarter and half year ended 30th September 2025. Pursuant to Regulation 29(1)(e) and 42 of the Listing Regulations, Ajanta Pharma has informed that, at the aforesaid Board Meeting, the Board of Directors will also consider: a. declaration of 1st interim dividend for the financial year ending 31st March 2026; and b. fixation of Monday, 10th November 2025 as the Record Date for the payment of interim dividend, if declared.
The above information is a part of company’s filings submitted to BSE.
